Target intelligence / Profile preview

Silica nanoparticle silanol group (Si-OH)

Target
Si-OH
Molecular classification
Inorganic surface functional group, Nanomaterial component
01

Overview

Silanol groups (Si-OH) are the primary chemical moieties found on the surface of both mesoporous and dense silica nanoparticles. These groups determine the surface chemistry, hydrophilicity, and reactivity of the nanoparticles, playing a critical role in how they interact with biological systems. While not a therapeutic target in the traditional sense of a biological receptor or enzyme, silanol groups are the active sites responsible for the material's biocompatibility or toxicity. They are frequently exploited in nanomedicine as sites for covalent functionalization with ligands, polymers, or drugs to create targeted delivery vehicles. However, exposed silanols can also lead to adverse effects such as hemolysis and the generation of reactive oxygen species, making their density and distribution a key focus in the design of safe silica-based biomaterials.

Other names
Surface silanolsSilanol moietiesSilicon hydroxyl groupsSilica surface silanols
02

Mechanism of action

Silanol groups act as chemically active sites on the surface of silica nanoparticles that interact with biological membranes through hydrogen bonding and electrostatic interactions with phospholipids and proteins. In drug delivery, they serve as anchors for functionalization or as adsorption sites for therapeutic payloads. In toxicology, deprotonated silanols (SiO-) can interact with quaternary ammonium groups in membrane phospholipids, leading to membrane distortion and lysis.

03

Biological functions

Membrane disruptionProtein corona formationReactive oxygen species (ROS) generationCellular uptake mediation
04

Disease associations

SilicosisInflammationHemolysisPulmonary fibrosis
05

Safety considerations

Hemotoxicity (hemolysis of red blood cells)Pro-inflammatory responseCytotoxicity due to membrane damagePotential for irreversible lung damage if inhaled
06

Interacting drugs

Silane coupling agents (e.g., APTES)

3 more in the full profile.

Beyond the preview

Go deeper on Silica nanoparticle silanol group (Si-OH).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Silica nanoparticle silanol group (Si-OH).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call